APA
Newey A., Griffiths B., Michaux J., Pak H. S., Stevenson B. J., Woolston A., Semiannikova M., Spain G., Barber L. J., Matthews N., Rao S., Watkins D., Chau I., Coukos G., Racle J., Gfeller D., Starling N., Cunningham D., Bassani-Sternberg M. & Gerlinger M. (20200702). Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. : Journal for immunotherapy of cancer.
Chicago
Newey Alice, Griffiths Beatrice, Michaux Justine, Pak Hui Song, Stevenson Brian J, Woolston Andrew, Semiannikova Maria, Spain Georgia, Barber Louise J, Matthews Nik, Rao Sheela, Watkins David, Chau Ian, Coukos George, Racle Julien, Gfeller David, Starling Naureen, Cunningham David, Bassani-Sternberg Michal and Gerlinger Marco. 20200702. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. : Journal for immunotherapy of cancer.
Harvard
Newey A., Griffiths B., Michaux J., Pak H. S., Stevenson B. J., Woolston A., Semiannikova M., Spain G., Barber L. J., Matthews N., Rao S., Watkins D., Chau I., Coukos G., Racle J., Gfeller D., Starling N., Cunningham D., Bassani-Sternberg M. and Gerlinger M. (20200702). Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. : Journal for immunotherapy of cancer.
MLA
Newey Alice, Griffiths Beatrice, Michaux Justine, Pak Hui Song, Stevenson Brian J, Woolston Andrew, Semiannikova Maria, Spain Georgia, Barber Louise J, Matthews Nik, Rao Sheela, Watkins David, Chau Ian, Coukos George, Racle Julien, Gfeller David, Starling Naureen, Cunningham David, Bassani-Sternberg Michal and Gerlinger Marco. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. : Journal for immunotherapy of cancer. 20200702.